| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,795 | 6,789 | 8,514 | 5,985 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 7,795 | 6,789 | 8,514 | 5,985 | | | Operating Expenses | | Research Development | 11,099 | 7,418 | 7,033 | 10,377 | | Selling General and Administrative | 6,468 | 5,568 | 2,885 | 2,980 | | Non Recurring | 12,152 |
-
| 98 | 1,188 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21,924) | (6,197) | (1,502) | (8,560) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 328 | 382 | 841 | | Earnings Before Interest And Taxes | (21,758) | (5,869) | (1,120) | (7,719) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (21,758) | (5,869) | (1,120) | (7,719) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,672) | (5,869) | (1,120) | (7,719) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,672) | (5,869) | (1,120) | (7,719) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,672) | ($5,869) | ($1,120) | ($7,719) |
|
0.26% Nasdaq 
Income Statement
